PLC News

Plc Market news covers the latest developments on the Alternative Investment Market, the London Stock Exchange’s venue for smaller, growth‑orientated companies. This section includes updates on company admissions and delisting’s, fund‑raisings and IPOs, share‑price movements, mergers and acquisitions, board appointments and departures, regulatory and policy changes

Brooks Macdonald completes acquisition of LIFT-Financial Group

Brooks Macdonald Group completes the strategic acquisition of LIFT-Financial Group, boosting assets under advice by £1.6bn and enhancing client services...

SigmaRoc delivers resilient results, EBITDA and EPS ahead of expectations

SigmaRoc plc (LON:SRC), a major European lime and minerals group, reports FY24 trading results with revenue surging 72% YoY, outperforming expectations...

hVIVO and Inhalon Biopharma partner to test inhaled antiviral for RSV

hVIVO plc partners with Inhalon Biopharma to test IN-002, an inhaled antiviral for RSV, in a Phase 2a trial using their RSV Human Challenge Model...

Cohort completes acquisition of EM Solutions

Cohort plc (LON: CHRT) expands its global reach by acquiring EM Solutions Pty Ltd, enhancing its defense and government tech offerings worldwide...

Alliance Pharma reports mixed FY2024 results

Alliance Pharma plc (LON: APH) reports a 1% drop in FY 2024 revenues, but with strong gains in Kelo-Cote, MacuShield, and Hydromol segments...

Quadrise raises £6.53 million via Placing, the Subscription and Retail Offer

Quadrise Plc (LON:QED) reports a significantly oversubscribed £2 million Retail Offer, part of a larger £6.53 million fundraising effort for clean energy solutions...

Nuformix advances NXP002 programme with £168,750 Placing

Nuformix plc (LON:NFX) raises £168,750 for fibrosis drug development through a new share placing, advancing its NXP002 programme and corporate goals...

Poolbeg Pharma granted extension to PUSU Deadline

HOOKIPA Pharma and Poolbeg Pharma enter talks for a potential acquisition aimed at developing next-generation immunotherapies for critical medical needs...

Strix Group reports FY24 profits ahead of market consensus

Strix Group Plc sees FY24 profits surpass expectations, driven by innovation and strong market presence, with new product launches fueling future growth...

Union Jack Oil plc Positive update on Moccasin 1-13 Well, Oklahoma

Union Jack Oil plc (LON:UJO, OTCQB: UJOGF) reports promising developments at its Moccasin 1-13 well in Oklahoma, highlighting potential oil prospects...

Hardide plc Annual results FY September 2024, well placed for growth, cash generation and value creation

Hardide plc reports FY24 results, showcasing revenue growth, improved profitability, and strategic advancements in aerospace and industrial sectors...

REACT Group plc Final results show increased revenues, growth and profit

REACT Group Plc (LON:REAT) reports strong financial growth for 2024, driven by a 6% revenue boost to £20.7m and enhanced profitability through strategic initiatives...

Nuformix plc Annual Results for the period ended 30 September 2024

Nuformix plc (LON:NFX) targets unmet needs in fibrosis and oncology via drug repurposing, focusing on partnering its NXP002 lead program for IPF and PPF...

hVIVO plc Acquires two Clinical Research Units from CRS for €10.0m

hVIVO expands its clinical footprint by acquiring CRS, a German CRO, adding Phase I & II trial capabilities in Europe, enhancing strategic growth for 2025-2026...

Versarien raises £246,038 via Placing

Versarien plc (LON:VRS) raises £246,038 through a placement of 745 million new shares, enhancing corporate funding and shareholder transparency...

Nuformix submits NXP002 Orphan Drug Designation Application to EMA

Nuformix plc (LON:NFX) advances NXP002 for Idiopathic Pulmonary Fibrosis, applying for Orphan Drug Designation with European Medicines Agency...

Aptamer Group reports on significant commercial and technical progress in H1 report

Aptamer Group plc reports progress on key projects in its H1 2025 trading update, highlighting partnerships with Unilever and Alzheimer's biomarker validation...

Quadrise appoints marine expert Tony Foster as Non-Executive Director

Quadrise Plc (LON: QED) welcomes Tony Foster as Non-Executive Director, enhancing their maritime and decarbonisation expertise from February 2025...

Time Finance reports record lending book, fourteen consecutive quarters of growth

Time Finance plc's interim results show impressive growth, with a 16% revenue increase and a 44% rise in profit. Explore their strategic updates...

Diversified Energy expands asset base with Maverick Natural Resources acquisition

Diversified Energy acquires Maverick Natural Resources for $1.275 billion, boosting production scale, free cash flow, and sustainable long-term growth...
Search

Funds

Search Results for: 2016

Brooks Macdonald completes acquisition of LIFT-Financial Group

Brooks Macdonald Group completes the strategic acquisition of LIFT-Financial Group, boosting assets under advice by £1.6bn and enhancing client services...

SigmaRoc delivers resilient results, EBITDA and EPS ahead of expectations

SigmaRoc plc (LON:SRC), a major European lime and minerals group, reports FY24 trading results with revenue surging 72% YoY, outperforming expectations...

hVIVO and Inhalon Biopharma partner to test inhaled antiviral for RSV

hVIVO plc partners with Inhalon Biopharma to test IN-002, an inhaled antiviral for RSV, in a Phase 2a trial using their RSV Human Challenge Model...

Cohort completes acquisition of EM Solutions

Cohort plc (LON: CHRT) expands its global reach by acquiring EM Solutions Pty Ltd, enhancing its defense and government tech offerings worldwide...

Alliance Pharma reports mixed FY2024 results

Alliance Pharma plc (LON: APH) reports a 1% drop in FY 2024 revenues, but with strong gains in Kelo-Cote, MacuShield, and Hydromol segments...

Quadrise raises £6.53 million via Placing, the Subscription and Retail Offer

Quadrise Plc (LON:QED) reports a significantly oversubscribed £2 million Retail Offer, part of a larger £6.53 million fundraising effort for clean energy solutions...

Nuformix advances NXP002 programme with £168,750 Placing

Nuformix plc (LON:NFX) raises £168,750 for fibrosis drug development through a new share placing, advancing its NXP002 programme and corporate goals...

Poolbeg Pharma granted extension to PUSU Deadline

HOOKIPA Pharma and Poolbeg Pharma enter talks for a potential acquisition aimed at developing next-generation immunotherapies for critical medical needs...

Strix Group reports FY24 profits ahead of market consensus

Strix Group Plc sees FY24 profits surpass expectations, driven by innovation and strong market presence, with new product launches fueling future growth...

Union Jack Oil plc Positive update on Moccasin 1-13 Well, Oklahoma

Union Jack Oil plc (LON:UJO, OTCQB: UJOGF) reports promising developments at its Moccasin 1-13 well in Oklahoma, highlighting potential oil prospects...

Hardide plc Annual results FY September 2024, well placed for growth, cash generation and value creation

Hardide plc reports FY24 results, showcasing revenue growth, improved profitability, and strategic advancements in aerospace and industrial sectors...

REACT Group plc Final results show increased revenues, growth and profit

REACT Group Plc (LON:REAT) reports strong financial growth for 2024, driven by a 6% revenue boost to £20.7m and enhanced profitability through strategic initiatives...

Nuformix plc Annual Results for the period ended 30 September 2024

Nuformix plc (LON:NFX) targets unmet needs in fibrosis and oncology via drug repurposing, focusing on partnering its NXP002 lead program for IPF and PPF...

hVIVO plc Acquires two Clinical Research Units from CRS for €10.0m

hVIVO expands its clinical footprint by acquiring CRS, a German CRO, adding Phase I & II trial capabilities in Europe, enhancing strategic growth for 2025-2026...

Versarien raises £246,038 via Placing

Versarien plc (LON:VRS) raises £246,038 through a placement of 745 million new shares, enhancing corporate funding and shareholder transparency...

Nuformix submits NXP002 Orphan Drug Designation Application to EMA

Nuformix plc (LON:NFX) advances NXP002 for Idiopathic Pulmonary Fibrosis, applying for Orphan Drug Designation with European Medicines Agency...

Aptamer Group reports on significant commercial and technical progress in H1 report

Aptamer Group plc reports progress on key projects in its H1 2025 trading update, highlighting partnerships with Unilever and Alzheimer's biomarker validation...

Quadrise appoints marine expert Tony Foster as Non-Executive Director

Quadrise Plc (LON: QED) welcomes Tony Foster as Non-Executive Director, enhancing their maritime and decarbonisation expertise from February 2025...

Time Finance reports record lending book, fourteen consecutive quarters of growth

Time Finance plc's interim results show impressive growth, with a 16% revenue increase and a 44% rise in profit. Explore their strategic updates...

Diversified Energy expands asset base with Maverick Natural Resources acquisition

Diversified Energy acquires Maverick Natural Resources for $1.275 billion, boosting production scale, free cash flow, and sustainable long-term growth...
Search

Funds

PLC News

FTSE 100

Funds